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Abstract

Author Manuscript

Glycopeptide-level mass spectrometry (MS) and tandem mass spectrometry (MS/MS) analyses are
commonly performed to establish site-specific protein glycosylation profiles that are of central
importance to gaining structure-function insights on glycoproteins. Confoundingly, the complete
characterization of glycopeptide connectivity usually requires the acquisition of multiple MS/MS
fragmentation spectra. Complementary ion fragmentation techniques such as collision-induced
dissociation (CID) and electron transfer dissociation (ETD) are often applied in concert to address
this need. While structurally informative, the requirement for acquisition of two MS/MS spectra
per analyte places considerable limitations upon the breadth and depth of large-scale
glycoproteomic inquiry. Here, a previously developed method of multiplexing CID and ETD is
applied to the study of glycopeptides for the first time. Integration of the two dissociation methods
was accomplished through addition of an ion mobility (IM) dimension that disperses the two
stages of MS/MS in time. This allows the two MS/MS spectra to be acquired within a few
milliseconds of one another, and to be deconvoluted in post-processing. Furthermore, the method
allows both fragmentation readouts to be obtained from the same precursor ion packet, thus
reducing the inefficiencies imposed by separate CID and ETD acquisitions and the relatively poor
precursor ion to fragment ion conversion typical of ETD. N-linked glycopeptide ions ranging in
molecular weight from 1800 to 6500 u were generated from four model glycoproteins that
collectively encompassed paucimannosidic, high mannose, and complex types of N-glycosylation.
In each case, IM-resolved CID and ETD events provided complete coverage of the glycan
topology and peptide sequence coverages ranging from 48.4% (over 32 amino acid residues) to
85.7% (over eight amino acid residues). The potential of this method for large-scale
glycoproteomic analysis is discussed.
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One packet of N-glycopeptide precursors can be successively probed by CID and ETD, with
fragmentation spectra deconvoluted via IM.
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Introduction

Author Manuscript

Glycosylation is the most ubiquitous, diverse, and elaborate form of protein modification;
accordingly, glycans enzymatically linked to proteins serve highly varied and indispensable
functions of life.1–4 These include vital contributions to the folding and stability of
glycoproteins, involvement as essential elements of intermolecular recognition, and action as
agents of cellular signaling pathways.5–10 Altered protein glycosylation is also a hallmark of
numerous human diseases, where perturbations in the structures or compositions of proteinmodifying oligosaccharides can either indicate or instigate an unhealthy condition.11–20 The
foregoing considerations have served to motivate great interest in the detailed
characterization of glycoproteomic systems; nevertheless, the protein-specific and sitespecific determination of glycosylation profiles is fraught with complexities – both
biological and technical – and remains well outside the realm of routine analysis.21–24

Author Manuscript

Despite the challenges involved, mass spectrometry (MS) of proteolytic glycopeptides
provides a means of associating specific glycan compositions and structures with defined
positions on the corresponding glycoprotein.25–34 These experiments rely on tandem mass
spectrometry (MS/MS) methods in order to establish the composition and topology of the
oligosaccharide, the sequence of the polypeptide, and the site of glycosylation; however, the
entirety of the glycopeptide connectivity is seldom apparent from any single MS/MS
spectrum. Thus, the complementarity of multiple ion dissociation methods is frequently
leveraged in order to garner a more complete structural view.35–42 While the
photodissociation methods of infrared multiphoton dissociation (IRMPD)43–45 and
ultraviolet photodissociation (UVPD)46–48 have shown significant potential to acquire
highly informative MS/MS spectra for glycopeptides, a more common and more widely
available approach is to pair collision-induced dissociation (CID) and electron transfer
dissociation (ETD).49–52 This pairing affords a convenient means of capturing both glycan
connectivity information (via the CID spectrum), as well as peptide sequence and glycosite
(via the ETD spectrum). When used together to collect complementary fragmentation
spectra, CID and ETD are generally performed separately, yielding two separate MS/MS
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spectra. Unfortunately, this comes with the penalty of increased sample consumption and
reduced duty cycle per analyte characterized.
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One approach to multiplexing multiple MS/MS acquisitions involves the incorporation of an
ion mobility (IM) dimension. In one experiment of this type, IM-resolved precursor ions can
be subjected to CID as they exit the collision cell. In this so-called “time-aligned parallel”
dissociation, the ions resulting from post-IM fragmentation appear at the same IM drift time
as their corresponding precursor ion. This general approach has been applied to an
assortment of MS/MS analyses, ranging from small molecules to non-covalent protein
complexes.53–57 Subsequent reports have suggested a similar strategy which integrates CID
and ETD by IM separation of mass-selected precursor ions that had either undergone an
electron transfer (ET) reaction or no reaction (NR), followed by vibrational activation (VA).
58, 59 Our laboratory recently reported on the application of this approach to unmodified
polypeptides of varying molecular weights, and found that complementary sequence
information could be gathered in much the same manner as acquiring separate CID and ETD
spectra, yet with higher overall precursor ion utilization efficiency and improved instrument
duty cycle.60 Given these characteristics, IM-based multiplexed acquisition of CID and ETD
spectra is rendered a compelling option for high-throughput analysis.
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Here, we report the first example of IM-resolved CID and ETD of protonated N-linked
glycopeptide ions. The analytes considered encompass a wide range of molecular weights,
charge states, peptide compositions, and glycan structures. In each case, complementary
fragmentation information was conveyed by high-quality CID and ETD spectra which were
acquired from the same mass-selected packet of precursor ions. These results suggest that
the approach is generalizable and provides access to orthogonal structural information for
even highly challenging N-glycopeptide analyte ions. While these analyses returned similar
advantages as previously described for analysis of unmodified peptides, we also note that
this combination of analytical dimensions is capable of delivering additional benefits –
particularly as IM continues to mature in the areas of oligosaccharide and glycoconjugate
analysis.61–70

Experimental
Model N-Glycopeptide Preparation.

Author Manuscript

Four well-characterized glycoproteins were chosen as sources of N-glycopeptides for this
study: horseradish peroxidase (HRP), bovine ribonuclease B (BRB), coral tree lectin (CTL),
and bovine serum fetuin (BSF). Proteomics grade trypsin, HRP, BRB, and BSF were
purchased from Sigma-Aldrich (St. Louis, MO, USA). CTL was purchased from Vector
Laboratories (Burlingame, CA, USA). For each glycoprotein, a 2 mg/mL solution was
prepared in 8 M urea with 50 mM ammonium bicarbonate (pH 7.5). A 50 μL portion of this
denatured glycoprotein solution was combined with 10 μL dithiothreitol (450 mM in 50 mM
ammonium bicarbonate, pH 7.5; incubated at 55°C for 1 h) followed by 10 μL
iodoacetamide (500 mM in 50 mM ammonium bicarbonate, pH 7.5; incubated in the dark at
25°C for 1 h) for disulfide reduction and cysteine alkylation. The mixture was next diluted to
a total volume of 250 μL with 50 mM ammonium bicarbonate (pH 7.5) to reduce the urea
concentration to 1.6 M, and treated with 5 μL proteomics grade trypsin (0.5 μg/μL;
Analyst. Author manuscript; available in PMC 2020 April 20.
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incubated at 37°C for 18 h). Glycoprotein digests were reduced in volume to approximately
10 μL by vacuum centrifugation (Speed Vac SC110; Thermo Savant, Holbrook, NY, USA),
then brought to a final volume of 100 μL by reconstituting in 0.1% formic acid.
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Glycopeptides in the reconstituted preparations were desalted and enriched by solid-phase
extraction (SPE) using a zwitterionic hydrophilic interaction liquid chromatography (ZICHILIC) stationary phase in a micropipette tip format (Protea Biosciences, Somerset, NJ,
USA). Formic acid was acquired from Sigma-Aldrich; HPLC grade acetonitrile was
acquired from Fisher Scientific (Fair Lawn, NJ, USA); and HPLC grade water was acquired
from Burdick and Jackson (Muskegon, MI, USA). SPE was carried out by first wetting the
ZIC-HILIC tips in water, then equilibrating in 80% acetonitrile with 0.1% formic acid. Next,
4 μL of reconstituted aqueous digest was added to 16 μL of acetonitrile, and the resulting
mixture of reconstituted digest in 80% acetonitrile was loaded onto the ZIC-HILIC SPE tip.
The stationary phase was then rinsed in 80% acetonitrile with 0.1% formic acid. Finally, the
desalted and enriched glycopeptides were eluted into 0.1% formic acid.
Mass Spectrometry and Ion Mobility.
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All MS, MS/MS, and IM experiments were performed using a quadrupole time-of-flight
mass spectrometer (Q-TOF-MS) equipped with a traveling wave IM cell71–74 and the
capability to perform both CID and ETD based MS/MS experiments75, 76 (Synapt G2-S
HDMS; Waters Corporation, Manchester, UK). For sample introduction by nanoelectrospray ionization (nESI), tapered glass emitters were fabricated in-house from melting
point capillaries (1.5 – 1.8 × 100 mm; Corning Pyrex, Corning, NY, USA) using a vertical
micropipette puller (David Kopf Instruments, Tujunga, CA, USA). Approximately 5 – 10 μL
of each purified N-glycopeptide preparation was transferred to an emitter using a fine-point
syringe (Hamilton, Reno, NV, USA). The emitter was then placed on a home-built holder
designed to mate to the commercial nESI source of the instrument, while also placing the
sample solution within the emitter in contact with a platinum wire that delivered the
necessary DC potential. An emitter voltage of 0.6 – 1.2 kV was applied to initiate nESI. The
sampling cone potential and the source DC offset were each set to 10 V, the ion source block
temperature was held at 80 – 100°C, and the flow of nitrogen cone gas was maintained at 50
L/h.

Author Manuscript

Negatively charged radical reagent ions for ET reactions were generated by glow discharge
ionization of 1,4-dicyanobenzene (Sigma-Aldrich) as previously described.75, 76 Vapors of
the reagent were swept from a reservoir and through the hollow discharge pin by a 25
mL/min flow of nitrogen make-up gas, and the discharge current was set to 30 – 50 μA.
Quadrupole-selected reagent ions were stored in the trap region (i.e., pre-IM) stacked ring
ion guide (SRIG) with a refill duration of 0.1 s and a refill interval of 1.0 s. The pressure in
the trap cell was maintained at 5.0 – 6.0 × 10−2 mbar by a 12 – 14 mL/min flow of helium
bath gas, and the RF amplitude applied to the trap cell SRIG was set to 450 – 500 V.
Quadrupole-selected analyte ions were then directed to the trap cell. The trap cell traveling
DC wave velocity was set to 300 m/s, while the height of this pulse was adjusted to
modulate the reagent ion / analyte ion co-confinement time. The ion-ion interaction time was
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minimized by application of a 1.5 V wave height (thus preventing ET reactions), or
maximized by application of a 0.1 V wave height (thus facilitating ET reactions).
Separation of unreacted precursor ions and their corresponding charge-reduced ET products
was carried out in the IM cell SRIG, which was held at a pressure 3.1 – 3.5 mbar by a 40
mL/min flow of nitrogen drift gas to the main body of the cell. The entrance interface region
of the cell was maintained at a pressure of 1.2 – 1.4 × 10−3 mbar by a 150 mL/min flow of
helium. The RF amplitude applied to the IM SRIG was set to 250 – 300 V, while the IM cell
traveling DC wave velocity was set between 650 – 1200 m/s with a wave height between 25
– 40 V, depending on the analyte. Ion packets were delivered to the IM cell from the trap cell
using a 200 – 500 μs gating pulse and a trap DC bias (i.e., the potential difference between
trap cell and the IM cell) of 25 – 35 V, depending on the analyte.

Author Manuscript

IM-separated precursor ions and ET product ions were caused to undergo CID and ETD,
respectively, through vibrational activation in the transfer region (i.e., post-IM) SRIG. Ions
exiting the IM cell were accelerated into the transfer cell through a potential difference
(ΔUVA) of 25 – 45 V, depending on the analyte. The pressure in the transfer cell was
maintained at 1.6 – 1.8 × 10−2 mbar by a 0.5 – 0.6 mL/min flow of argon collision gas, and
the RF amplitude applied to the transfer cell SRIG was set to 350 – 380 V. The traveling DC
wave applied to the transfer SRIG had a velocity of between 110 – 200 m/s and a height of
4.0 – 5.0 V. Ions exiting the transfer cell were then analyzed by TOF-MS over the range of
m/z 50 – 3000.
Data Processing and Presentation.

Author Manuscript

MassLynx 4.1 (Waters) was used for instrument control, data acquisition, and rudimentary
MS data processing (summing scans, smoothing spectra, etc.). DriftScope 2.7 (Waters) was
used for basic handling of IM data, including extraction of mass spectra corresponding to
selected drift time windows. Further analysis and visualization of IM and MS data was
carried out using purpose-built software tools written and executed in IGOR Pro 6
(WaveMetrics, Lake Oswego, OR, USA). Peak assignment and annotation of MS/MS
spectra was conducted in accord with the Roepstorff / Fohlman and Domon / Costello
nomenclatures for polypeptide and oligosaccharide fragmentations, respectively.77, 78 When
applying these fragment ion naming systems, glycan fragments were assigned using
uppercase letters, while peptide fragments were assigned using lowercase letters. Precursor
ion cleavage maps were rendered using standard one-letter amino acid abbreviations and the
monosaccharide symbology promulgated by Varki et al. and the Consortium for Functional
Glycobiology.79, 80 Non-symbolic monosaccharide abbreviations were also used for the
monosaccharides xylose (Xyl), fucose (Fuc), mannose (Man), galactose (Gal), Nacetylglucosamine (GlcNAc), and N-acetylneuraminic acid (NeuAc).

Author Manuscript

Results
Overview.
The schematic flowchart shown in Figure 1 briefly illustrates the sequence of events
employed to obtain IM-resolved CID and ETD spectra from a single packet of N-
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glycopeptide ions. In short, quadrupole-selected analyte and reagent ions were allowed to
interact such that a portion of the initial analyte ion population was converted to chargereduced radical analyte ions. The resulting mixture of analyte ions undergoing either no
reaction (NR) or electron transfer (ET) was then pulsed into the IM cell, where the two
components were readily separated in drift time due to their different charge states. As the
NR and ET ions exited the IM cell, they were subjected to vibrational activation (VA) by
acceleration through a DC offset (ΔUVA) and subsequent collisions with argon gas. This
resulted in the generation of two fragment ion populations detected by TOF-MS: those
arising from CID of the initial, unreacted analyte ions; and those resulting from
supplementally-activated ETD of the charge-reduced radical analyte ions. Because the two
intact ion populations were temporally resolved by IM, the corresponding groups of
fragment ions were likewise formed at different times. This ET-IM-VA sequence of events
thus allowed the two distinct dissociation spectra to be disentangled according to apparent
drift time.

Author Manuscript

HRP, BRB, CTL, and BSF were chosen as model glycoproteins for this study because each
has been well studied with respect to their glycosylation, which collectively encompasses a
wide range of N-glycan types including paucimannosidic (HRP and CTL), high mannose
(BRB), and complex-type (BSF) N-glycans. Additionally, trypsinolysis of these
glycoproteins results in glycopeptides with well-varied amino acid sequences about the
glycosylation site, both in terms of length and composition. Finally, N-glycopeptides from
the model glycoproteins discussed here have been previously studied by other research
groups using both CID and ETD, thus allowing the present approach to be compared to
relevant published examples as discussed in the succeeding sections. Taken together, the
chosen analytes provided a diverse set attributes of well-suited to a proof-of-concept study
on the application of IM-resolved CID and ETD for the analysis of N-linked glycopeptides.
Analysis of an N-Glycopeptide from HRP.

Author Manuscript

The first N-glycopeptide studied by sequential IM-resolved stages of CID and ETD was
derived from HRP (UniProtKB P00433). This glycopeptide harbored a paucimannosidic Nglycan, and had the overall composition 184NVGLNR189 + GlcNAc2 Man3 Fuc1 Xyl1
(1841.79 u). The corresponding [M+2H]2+ ion (m/z = 921.89) was quadrupole selected and
subjected to ET-IM-VA as described above. ET to the initial precursor ion generated a
population of the charge-reduced product [M+2H]+• (m/z = 1843.79). Ions exiting the IM
cell were then energized using ΔUVA = 25 V. The resultant IM-MS heat map shown in
Figure 2a exhibited two major drift time bands corresponding to CID of the [M+2H]2+ ion
(the region labeled dt1) and ETD of the [M+2H]+• ion (the region labeled dt2). Some ion
signal was also noted outside of the two major drift time bands (i.e., between drift times of
about 4–8 ms). This was attributed to some proportion of the ion population undergoing
direct ETD, prior to IM separation. While this should be acknowledged as a potential
complication, these pre-IM fragments represented a small fraction of the total ion intensity
and did not obscure clear delineation of the CID and ETD spectra according to drift time.
Extraction of the m/z and relative intensity data from the dt1 band resulted in the mass
spectrum provided in Figure 2b. The spectrum was consistent with the expected CID
behavior of this glycopeptide, providing complete coverage of the glycan connectivity
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through a series of 11 fragment ions arising from Y-type glycosidic cleavages.
Complementarily, extraction of m/z and intensity data from the dt2 region of the heat map
provided the mass spectrum shown in Figure 2c. This ETD spectrum covered four of the five
possible N-Cα peptide backbone cleavages (i.e., 80% sequence coverage) by virtue of the z2
through z5 fragments. Interestingly, the ETD behavior of this glycopeptide deviates from a
general trend noted by Desaire and coworkers, in which c-series ions tend to be predominant
in the ETD spectra of N-glycopeptides harboring the glycan near the C-terminus (and
likewise for z-series ions when the glycan is located near the N-terminus).81 In the present
case, the low initial charge state of the HRP glycopeptide ion (z = 2+), coupled with the
absence of basic amino acid side chains N-terminal of the glycosylation site, may have
preferentially favored the formation of fragments that retained the highly basic C-terminal
arginine residue (i.e., z ions). Cleavage of the oligosaccharide moiety was not apparent in the
ETD spectrum. The observed CID and ETD fragment ions were mapped onto diagrams of
the HRP N-glycopeptide in Figures 2d and 2e, respectively. The overall MS/MS coverage of
the glycopeptide structure was found to be quite consistent with previously published CID
and ETD spectra for the same precursor ion (including the abundant series of z-type ions
present in the ETD spectrum).82
Analysis of an N-Glycopeptide from BRB.
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A high mannose N-glycopeptide generated by trypsinolysis of BRB (UniProtKB P61823)
was next considered. With an overall composition of58SRNLTKDR65 + GlcNAc2 Man5
(2204.96 u), this glycopeptide bore an N-glycan consisting of seven neutral monosaccharide
residues. While in this respect the oligosaccharide moiety was similar to that of the HRP
glycopeptide, the two glycans also differed in that the HRP glycan was comprised of four
different monosaccharides (GlcNAc, Man, Fuc, and Xyl), while the BRB glycan was
comprised of only two different monosaccharides (GlcNAc and Man). This rendered the
BRB glycan of greater molecular weight, yet lower compositional complexity. The BRB and
HRP glycopeptides also differed in the lengths of their polypeptide chains (eight vs. six
amino acid residues, respectively). The [M+3H]3+ ion (m/z = 735.99) was quadrupole
selected and underwent sub-stoichiometric ET reaction to yield a mixture of the unreacted
precursor ion and the [M+3H]2+• ion (m/z = 1103.99). IM separation and collisional
activation of these ions (ΔUVA = 25 V) produced the results summarized in Figure 3. The
two major drift time bands appearing in the IM-MS heat map (Figure 3a) were wellresolved, readily allowing extraction of the individual fragmentation spectra arising from
CID (Figure 3b) and ETD (Figure 3c). As in the previous example, some ETD product ions
formed prior to introduction to the IM separator were apparent in the heat map (i.e., in the
drift time region of 7 ms and greater); however, these again accounted for a relatively minor
fraction of the total ion signal and did not materially complicate the analysis. Among these,
a low abundance yet noticeable grouping of signals observed in Figure 3a with drift times in
the 12 – 14 ms range and m/z values of 1500 – 1600. One potential explanation for these
fragments is that they arose from dissociation of a lower mobility (i.e., doubly chargereduced) ET product; however, no direct evidence for the [M+3H]+•• ion was found.
Alternatively, this grouping of fragments may simply have similar mobilities and arose from
pre-IM ETD. Regardless of the origin of these minor fragments, they also appeared in the
dt2 band ETD spectrum, and thus did not provide any additional analytical information. The
Analyst. Author manuscript; available in PMC 2020 April 20.
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CID spectrum afforded complete glycosidic coverage of the GlcNAc2 Man5 N-glycan
(Figure 3d). This was realized through a series of Y ions involving sequential loss of all five
Man residues, eventually leading to the Y2 fragment. This series of fragments was observed
in both the triply-charged and doubly-charged states. The Y1 fragment (SRNLTKDR +
GlcNAc) was also observed as a doubly-charged ion. Meanwhile, the ETD spectrum
furnished 10 peptide backbone fragment ions (c2-c3; c5; c7; z1-z6) that collectively covered
six of the seven possible N-Cα cleavages for 85.7% sequence coverage (Figure 3e). The
consecutive fragment ion pairs c2-c3 and z5-z6 allowed explicit site localization of the Nglycan, while no evidence of glycan fragmentation was detected in the ETD spectrum. This
duplexed approach yielded CID and ETD spectra that conveyed essentially the same
structural information as those found in previous, more conventional studies of BRB
glycopeptides.49, 50, 83–85 The cited examples for comparison included analytes in which the
GlcNAc2 Man5 N-glycan was linked to the SRNLTKDR peptide chain (as studied here), as
well as the SRNLTK peptide chain (as more frequently noted in the literature), and also
encompasses precursor ions in the z = 2+ and z = 3+ charge states.
Analysis of an N-Glycopeptide from CTL.
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The next tryptic N-glycopeptide for study was obtained from CTL (UniProtKB P83410).
With the overall composition 100 SKPAQGYGYLGVFNNSK116 + GlcNAc2 Man3 Fuc1
Xyl1 (2999.33 u), this analyte was considerably larger than the previously considered
examples; however, the paucimannosidic oligosaccharide modifying this glycopeptide was
identical in structure to that present on the HRP glycopeptide. Thus, the CTL glycopeptide
primarily differed from the HRP and BRB glycopeptides in the substantially greater length
of the polypeptide chain (17 amino acid residues). Importantly, while there were two
asparagine residues present within the peptide sequence of this analyte, only one of these
occurred in the context of a consensus sequon for N-glycosylation (NXS or NXT, where X is
any amino acid, proline excepted). Thus, N113 was the only site of glycosylation.
Quadrupole selection of the [M+3H]3+ ion (m/z = 1000.78) followed by reaction with ET
reagent ions resulted in the formation of charge-reduced [M+3H]2+• product ions (m/z =
1501.17). Post-activation of the IM-resolved NR and ET ions (ΔUVA = 40 V) yielded the
characteristic IM-MS drift time vs. m/z heat map with two horizontal bands of fragment
ions, each occurring within a unique region of apparent ion mobility space (Figure 4a).
Unlike the comparatively smaller glycopeptides previously examined, this IM-MS heat map
was free of any appreciable pre-IM ETD fragmentation. The glycosidic topology of the
glycan group was fully represented in the CID spectrum (Figure 4b), with a series of doublycharged fragments demonstrating stepwise monosaccharide losses which ultimately revealed
the unmodified peptide as the Y0 fragment. While not shown in Figure 4b, a comparable
series of triply-charged Y ions was observed over a lower range of m/z, but provided no new
information (and have thus been omitted from Figure 4b in the interest of clarity). The ETD
spectrum (Figure 4c) was largely comprised of a contiguous series of c-type ions (c3-c13),
collectively accounting for 11 of the 15 available N-Cα cleavage products (i.e., not
considering the c2 cleavage N-terminal to the proline residue, which does not yield a
fragment upon scission). This corresponds to production of 73.3% of the possible c ions, or
an overall peptide sequence coverage of 68.8%. The presence of a predominant series of c
ions was consistent with a general trend noticed by Desaire and coworkers, in which c-type
Analyst. Author manuscript; available in PMC 2020 April 20.
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ions were found to be the major ETD fragments for peptides with N-linked glycosites
localized to the C-terminus.81 As in the previous examples, the ETD spectrum was devoid of
any ions corresponding to glycan cleavage or loss. A diagram of the fragments observed in
both the CID and ETD spectra is provided in Figure 4d, where the information obtained by
means of the ET-IM-VA experimental sequence can be seen to compare favorably with those
obtained by other researchers using separate stages of CID and ETD.86, 87
Analysis of an N-Glycopeptide from BSF.
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The final model N-glycopeptide studied here was a tryptic fragment of BSF (UniProtKB
P12763) that harbored a triantennary, trisialylated complex-type N-linked oligosaccharide
structure. The overall composition of this glycopeptide was
72RPTGEVYDIEIDTLETTCHVLDPTPLANCSVR103 + GlcNAc Man Gal NeuAc
5
3
3
3
(6,531.77 u). With 14 monosaccharide residues and 32 amino acid residues, this analyte was
significantly more massive and compositionally heterogeneous than any of the model Nglycopeptides discussed in the preceding sections. Selection and ET reaction of the [M
+5H]5+ (m/z = 1307.36) led to the formation of a charge-reduced ET product ion, [M
+5H]4+• (m/z = 1634.20), as well as a doubly charge-reduced, even-electron ET product ion,
[M+5H]3+•• (m/z = 2178.94). IM sorting of the resultant ion population was carried out, with
subsequent vibrational activation accomplished with ΔUVA = 45 V. While the band of
fragment ions generated by CID of the NR precursor ions was well-isolated, the single ET
and double ET products were somewhat overlapped in drift time. This result was not entirely
unexpected, as the relative difference in charge between two successive charge states (and
the corresponding contribution to differences in mobility) decreases as the charge state
increases. Regardless of this overlap in drift time, two distinct regions of IM drift time were
defined which contained either unreacted precursor ions and fragments thereof (dt1), or a
mixture of single and double ET products (dt2) and their resulting fragments (Figure 5a). No
apparent contribution from direct ETD prior to IM separation was noted. The CID spectrum
(Figure 5b) was prominently populated by a series of 14 triply-charged Y-type
fragmentation products that were informative as to the stepwise deconstruction of the Nglycan, down to the reducing terminal GlcNAc residue (Y1 fragment). Some of the same
fragments were also observable as quadruply-charged ions at lower m/z (though for clarity
these are not shown in Figure 5b). Examination of the ETD spectrum (Figure 5c) allowed
assignment of 15 c and z fragment ions (c2-c12; c15; z1-z3), which in aggregate covered 15
out of 27 (or, 55.6%) of the N-Cα bonds able to be productively cleaved (i.e., ignoring
cleavages N-terminal to the three proline residues). The overall sequence coverage was
48.4%. The cleavage map provided in Figure 5d summarizes the information conveyed by
both the CID and ETD spectra. Notably, the ETD spectrum of the BSF glycopeptide also
exhibited a single Y-type loss of a NeuAc residue. Among the analytes studied here, this
was the only example of a CID-like glycan fragmentation occurring as a result of
supplementally-activated ETD; however, this result is perhaps unsurprising given the
tendency of NeuAc residues to undergo facile elimination under even gentle activation
conditions.88, 89 Ultimately, the appearance of this fragment did not interfere with
interpretation of the ETD spectrum. This example also illustrates that the ET-IM-VA scheme
can be applied to even large N-glycopeptides containing particularly labile terminal
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monosaccharides with minimal complication of the ETD spectrum by purely vibrational
activation / dissociation processes.
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Notably, previous efforts to obtain useful ETD spectra for this glycopeptide, and other
glycoforms thereof, have generally met with limited success. For instance, attempts by
Novotny and coworkers to generate ETD fragments from the same glycopeptide as the [M
+4H]4+ precursor ion yielded no peptide backbone fragments upon ETD.49 Another effort
by Desaire and coworkers focused on the non-sialylated analog of this glycopeptides in the
[M+4H]4+, [M+5H]5+, and [M+6H]6+ charge states.81 While the [M+6H]6+ precursor ion
with the highest of these charges states yielded a rich ETD spectrum covering the majority
of the peptide sequence, significant cleavage of the glycan moiety through collisionallyactivated processes was also reported. ETD of the [M+5H]5+ ion produced eight peptide c
and z fragments along the peptide backbone (though several or the ions assigned had very
low signal-to-noise ratios), as well as eight generally more abundant fragments arising from
cleavage or loss of the glycan due to vibrational activation / dissociation. In the same study,
the [M+4H]4+ yielded no useful product ions when ETD was attempted. Given this context,
the ability ET-IM-VA results for the BSF glycopeptide are particularly encouraging. Not
only was this approach able to produce an informative CID spectrum, but also an ETD
spectrum with 55.6% peptide sequence coverage and only a single sialic acid loss. This
improved performance apparent in the present work is likely attributable to the added
vibrational activation step, which is likely to bring about informative dissociation processes
in cases where a pure ETD experiment (i.e., with no vibrational activation) might not
succeed.

Conclusions
Author Manuscript

Here, we demonstrate the use of IM to temporally disperse mass-selected precursor ions and
their corresponding ET products and thus enable rapid sequential acquisition of high-quality
CID and ETD spectra for protonated N-linked glycopeptide ions. The IM dimension allows
the two fragmentation spectra to be cleanly disentangled from one another, thus simplifying
interpretation. Moreover, this approach allows the large fraction of precursor ions that fail to
undergo ET reactions to be productively utilized for acquiring a CID spectrum, rather than
being sacrificed to the generally low conversion efficiency and fragmentation efficiency of
typical ETD experiments. The model N-glycopeptide ions examined spanned a range of
polypeptide sequences, oligosaccharide compositions and structures, charge states, and
molecular weights. The capacity to successfully address this gamut of analytes suggests that
the method could be generalized to an even greater assortment of N-glycopeptides.

Author Manuscript

This analytical approach takes advantage of two key characteristics of the ET product ions.
First, under the conditions of these experiments, the ET product ions are sufficiently stable
to survive the approximately 10 ms IM separation with little or no direct ETD – an
advantage from the standpoint of partitioning the CID and ETD fragmentation events in
time. The significant lifetime of the charge-reduced radical species may be attributable in
part to collisional cooling in the trap region SRIG, which is operated at elevated pressure
when ET reactions are desired (this relaxes analyte and reagent ions to the radial center of
the cell, thus increasing the opportunity for ion-ion chemistry to occur). Second, the ΔUVA
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values suitable for supplemental activation of ET product ions conveniently coincide with
those that result in rich and informative CID spectra for the unreacted precursor ions. While
the two processes have different vibrational energy requirements, these can be
simultaneously satisfied by a single ΔUVA since the different charge states of the NR and ET
ions result in different kinetic energies prior to collisional activation (i.e., the NR ions with n
charges experience more energetic collisions than the ET ions with n-1 charges).
Furthermore, the optimum ΔUVA appears to scale roughly with precursor ion m/z. This
suggests that the approach could be extensible to glycoproteomic workflows including online chromatographic separations. One conceivable workflow would involve mass selection
of putative glycopeptide ions in a manner independent of fragmentation information (such as
carbohydrate oxonium ions produced by CID) using mass defect targeting.90–95 The ΔUVA
could then be set in a data-dependent manner according the precursor ion m/z. Such
multiplexed approaches that take advantage of useful physicochemical properties of
glycopeptides while efficiently leveraging complementary dissociation pathways will be
essential to expanding the accessible scope of glycoproteomic research. The use of IM to
duplex the acquisition of CID and ETD spectra demonstrates significant potential to
contribute to these endeavors.
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Figure 1.
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A pictorial representation of the ET-IM-VA experiment as applied to a model N-linked
glycopeptide from HRP (a key to the monosaccharide symbols provided in the inset). The
initial precursor ion with n positive charges is quadrupole (Q) selected, then transiently coconfined with negatively charged radical reagent ions (not shown). The precursor ions
undergoing either no reaction (NR) or an electron transfer (ET) reaction are then separated
by ion mobility (IM), which partitions the unreacted precursor ions (higher mobility) from
the charge-reduced ET products (lower mobility). The two mobility-sorted ion populations,
having drift times of dt1 and dt2 respectively, are next subjected to vibrational activation
(VA) as they exit the mobility cell. This results in collision-induced dissociation (CID) of the
unreacted precursor ions, while also providing supplemental activation that brings about
electron transfer dissociation (ETD) of the charge-reduced species. Due to the distinct drift
times of the NR and ET ion packets, the two dissociation experiments are temporally

Analyst. Author manuscript; available in PMC 2020 April 20.

Kolli et al.

Page 16

Author Manuscript

resolved. All resulting fragment ions are analyzed by time-of-flight mass spectrometry
(TOF-MS).
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Figure 2.
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ET-IM-VA analysis of the model N-glycopeptide derived from HRP. The IM-MS heat map is
shown in (a), with dashed boxes highlighting the fragment ion populations arising from CID
(dt1) and ETD (dt2). The CID spectrum extracted from the boxed dt1 region is given in (b),
while the ETD spectrum extracted from the boxed dt2 region is given in (c). Insets in (a) –
(c) summarize the experimental sequence corresponding to each plot. Cleavage maps
summarizing the observed CID (d) and ETD (e) fragments are also provided, and are
accompanied by a key to the monosaccharide symbols (inset). Note that in (a) the fragment
ions aligned with the dt1 band at m/z > 1100 are the singly-charged equivalents of their
doubly-charged analogs seen at m/z < 1100. These redundant fragment ions were omitted
from (b) for clarity.

Analyst. Author manuscript; available in PMC 2020 April 20.

Kolli et al.

Page 18

Author Manuscript
Author Manuscript
Author Manuscript

Figure 3.
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ET-IM-VA analysis of the model N-glycopeptide derived from BRB. The IM-MS heat map
is shown in (a), with dashed boxes highlighting the fragment ion populations arising from
CID (dt1) and ETD (dt2). The CID spectrum extracted from the boxed dt1 region is given in
(b), while the ETD spectrum extracted from the boxed dt2 region is given in (c). Insets in (a)
– (c) summarize the experimental sequence corresponding to each plot. Cleavage maps
summarizing the observed CID (d) and ETD (e) fragments are also provided, and are
accompanied by a key to the monosaccharide symbols (inset).
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Figure 4.
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ET-IM-VA analysis of the model N-glycopeptide derived from CTL. The IM-MS heat map
is shown in (a), with dashed boxes highlighting the fragment ion populations arising from
CID (dt1) and ETD (dt2). The CID spectrum extracted from the boxed dt1 region is given in
(b), while the ETD spectrum extracted from the boxed dt2 region is given in (c). Insets in (a)
– (c) summarize the experimental sequence corresponding to each plot. A cleavage map
summarizing the observed CID and ETD fragments is given in (d), and is accompanied by a
key to the monosaccharide symbols (inset).
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Figure 5.
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ET-IM-VA analysis of the model N-glycopeptide derived from BSF. The IM-MS heat map is
shown in (a), with dashed boxes highlighting the fragment ion populations arising from CID
(dt1) and ETD (dt2). The CID spectrum extracted from the boxed dt1 region is given in (b),
while the ETD spectrum extracted from the boxed dt2 region is given in (c). Insets in (a) –
(c) summarize the experimental sequence corresponding to each plot. A cleavage map
summarizing the observed CID and ETD fragments is given in (d), and is accompanied by a
key to the monosaccharide symbols (inset).
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